ArtisanBio
Main focus: CRISPR-edited cellular therapies
Company stage: Pre-clinical
Diseases (gene editing): Cancer
Genome editing tool: CRISPR
Funding stage: Private
Location: Denver, Colorado, USA
Website: https://artisancells.com/
Pipeline: https://artisancells.com/portfolio/
Gene-editing partnerships: Multiple undisclosed
ArtisanBio develops CRISPR-engineered cellular therapies to treat various undisclosed types of cancers. The company combines CRISPR gene editing with high-throughput workflows and data analysis to enable multiplex engineering of cells. The company yet has to disclose the details of its lead pre-clinical programmes.